Application of immune checkpoint inhibitors in immunotherapy for gastric cancer

Gastric cancer is the fifth most common cancer worldwide. With the development of immunotherapy, especially the application of immune checkpoint inhibitors (ICIs), the prognosis of advanced gastric cancer has improved. At present, ICIs combined with other therapies or dual ICI strategies in the trea...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Immunotherapy 2023-02, Vol.15 (2), p.101-115
Hauptverfasser:	Wu, Yi-Xiang, Zhou, Xiao-Yu, Wang, Jian-Qi, Chen, Gao-Min, Chen, Jin-Xu, Wang, Rong-Chang, Huang, Jiong-Qiang, Chen, Jing-Song
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers combination therapy gastric cancer Humans immune checkpoint inhibitors Immune Checkpoint Inhibitors - therapeutic use Immunotherapy predictive biomarkers Prognosis recent advances Stomach Neoplasms - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!